Phillip Barnes Net Worth

The estimated Net Worth of Phillip Barnes is at least $17.3 Thousand dollars as of 5 September 2023. Phillip Barnes owns over 5,000 units of VolitionRX Ltd stock worth over $17,256 and over the last 5 years he sold VNRX stock worth over $0. In addition, he makes $0 as Independent Director at VolitionRX Ltd.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Phillip Barnes VNRX stock SEC Form 4 insiders trading

Phillip has made over 1 trades of the VolitionRX Ltd stock since 2023, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of VNRX stock worth $6,500 on 5 September 2023.

The largest trade he's ever made was buying 5,000 units of VolitionRX Ltd stock on 5 September 2023 worth over $6,500. On average, Phillip trades about 417 units every 0 days since 2020. As of 5 September 2023 he still owns at least 24,686 units of VolitionRX Ltd stock.

You can see the complete history of Phillip Barnes stock trades at the bottom of the page.

Phillip Barnes biography

Dr. Phillip Barnes serves as Independent Director of the Company. Dr. Barnes holds a BSc and PhD from the University of London and a clinical medical degree (BM BCh) from the University of Oxford. Dr. Barnes is currently retired. Between 2009 and his retirement in 2016, Dr. Barnes served as Executive Medical Director on a number of United Kingdom Department of Health, National Health Service (“NHS”) hospital and Foundation Trust Boards. Between 2000 and 2009, Dr. Barnes was also involved in a number of national and regional advisory groups for the NHS and pharmaceutical industry. Dr. Barnes was Consultant Neurologist at King’s College Hospital, London, from 1995 to 2009 and Hon. Senior Lecturer in Neurology at King’s College London from 1999 to 2009. From 1995 to 1998, Dr. Barnes served as Clinical Director for Neurology and from 1998 until 2008 as Director of the King’s Neurosciences Centre, the United Kingdom’s largest Regional Neuroscience Centre. Our board of directors believes that Dr. Barnes is qualified to serve as a director of the Company based on his extensive experience both as a clinician and clinical manager within the United Kingdom’s NHS and related academic institutions.

How old is Phillip Barnes?

Phillip Barnes is 58, he's been the Independent Director of VolitionRX Ltd since 2019. There are 8 older and 13 younger executives at VolitionRX Ltd. The oldest executive at VolitionRX Ltd is Dr. Martin Charles Faulkes Ph.D., 77, who is the Exec. Chairman.

What's Phillip Barnes's mailing address?

Phillip's mailing address filed with the SEC is 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV, 89014.

Insiders trading at VolitionRX Ltd

Over the last 12 years, insiders at VolitionRX Ltd have traded over $775,239 worth of VolitionRX Ltd stock and bought 1,908,474 units worth $44,487,770,972 . The most active insiders traders include Guy Archibald Innes, Cameron John Reynolds, and Martin Charles Faulkes. On average, VolitionRX Ltd executives and independent directors trade stock every 43 days with the average trade being worth of $27,899. The most recent stock trade was executed by Guy Archibald Innes on 20 August 2024, trading 150,000 units of VNRX stock currently worth $100,500.

What does VolitionRX Ltd do?

volitionrx is a life sciences company whose goal is to make its non-invasive blood tests for cancer as common and simple to use as existing diabetic and cholesterol tests on similar formats. volitionrx’s development activities are currently centered in belgium with a focus on bringing its revolutionary diagnostic products to market first in europe, then the u.s. and worldwide. you can find more information about volitionrx at our website at www.volitionrx.com, on twitter at www.twitter.com/volitionrx, linkedin at http://www.linkedin.com/company/volitionrx or facebook at www.facebook.com/volitionrx.

Complete history of Phillip Barnes stock trades at VolitionRX Ltd

VolitionRX Ltd executives and stock owners

VolitionRX Ltd executives and other stock owners filed with the SEC include:

• Cameron Reynolds,
  President, Chief Executive Officer, Director
• Cameron Reynolds MBA,
  Founder, Group CEO, Pres & Director
• Jason Terrell,
  Chief Medical Officer and Head of US Operations
• Dr. Jason Bradley Terrell,
  Chief Medical Officer & Head of U.S. Operations
• David Vanston,
  Chief Financial Officer, Treasurer
• Jacob Micallef,
  Chief Scientific Officer
• Martin Faulkes,
  Executive Chairman of the Board
• Rodney Rootsaert,
  Corporate Secretary
• Dr. Martin Charles Faulkes Ph.D.,
  Exec. Chairman
• Dr. Jacob Vincent Micallef,
  Chief Scientific Officer
• Dr. Salvatore Thomas Butera,
  Chief Exec. Officer of Volition Veterinary Diagnostics Devel. LLC
• Scott Powell,
  IR Contact Officer
• Guy Innes,
  Independent Director
• Edward Futcher,
  Independent Director
• Alan Colman,
  Independent Director
• Phillip Barnes,
  Independent Director
• Gaetan Michel,
  Chief Executive Officer of Belgian Volition
• Jasmine Kway,
  Chief Executive Officer of Singapore Volition
• Nick Plummer,
  Group Gen. Counsel
• Scott Powell Ph.D.,
  Exec. VP of Investor Relations & CFO of Volition America Inc
• Dr. Mark Eccleston M.B.A., Ph.D.,
  Chief Technology Officer
• Dr. Gaetan Michel Ph.D.,
  Chief Operating Officer
• Terig Hughes,
  Group CFO & Treasurer
• Corp Ltd Cotterford Co Ltd ...,
  
• Richard Brudnick,
  
• Habib Skaff,
  Director
• David Matthew Kratochvil,
  Chief Financial Officer
• Rodney Gerard Concord Inter...,
  Secretary
• Nicholas Plummer,
  GC - Volition Diagnostics
• Ann Louise Batchelor,
  Group Chief Marketing Officer
• Kim Nguyen,
  
• Terig Hughes,
  Chief Financial Officer
• Mickie Henshall,
  
• Gael Forterre,
  Chief Commercial Officer
• Corp Ltd Hever Investments ...,
  
• Salvatore Thomas Butera,
  CEO - Volition Veterinary